Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Vertebral body reinforced calcium phosphate bone cement and preparation method thereof

A calcium phosphate bone cement, vertebral body technology, applied in prostheses, pharmaceutical formulations, drug delivery, etc., can solve the problems of slow degradation, less heat release, complications, etc., achieve good compressive strength, reduce dosage, reduce toxic effects

Active Publication Date: 2020-04-17
GUANGZHOU RAINHOME PHARM&TECH CO LTD
View PDF6 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] In 1987, Galibert et al. in France first reported the use of vertebroplasty (Vertebroplasty, VP) in the treatment of intractable painful C2 vertebral hemangiomas, and achieved good results. This technique has been extended and applied to benign and malignant vertebral tumors, bone Preventive treatment of loose vertebral fractures and vertebral bodies with a high risk of fracture. This technology injects PMMA bone cement into the affected vertebral body through the skin through a puncture needle to increase the strength and rigidity of the patient and prevent further vertebral body damage. Collapse can effectively relieve pain and improve the life of patients, but complications will also occur when implementing this technology
[0004] The composition of calcium phosphate bone cement is similar to that of human bone tissue. It has good biocompatibility and osteoconductivity. Low mechanical strength, inconsistent degradation rate and new bone formation rate, bone cement collapse during vertebroplasty can lead to pulmonary embolism, these defects limit its application in vertebroplasty

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0037] As an embodiment of the calcium phosphate bone cement described in the present invention, the calcium phosphate bone cement described in this embodiment includes solid phase powder and solidification liquid;

[0038] Preparation of modified bentonite: Weigh 10g of calcium-based bentonite with a diameter of 20μm, add 10g of water, raise the temperature to 70°C, stir at a constant temperature for 1.5h, then add 2g of quaternary ammonium salt-73, and continue stirring for 18h to obtain a compound quaternary ammonium salt- 73 bentonite solution, dried bentonite at 60°C, and crushed to 100 mesh to obtain modified bentonite.

[0039] Preparation of modified bentonite loaded with bone morphogenetic protein: Weigh modified bentonite and dissolve it in distilled water to make a bentonite solution with a mass concentration of 20% wt. Adding to the modified bentonite makes the BMP loaded in the modified bentonite gel.

[0040] Preparation of calcium phosphate bone cement: Weigh 9...

Embodiment 2

[0042] As an embodiment of the calcium phosphate bone cement described in the present invention, the calcium phosphate bone cement described in this embodiment includes solid phase powder and solidification liquid;

[0043] Preparation of modified bentonite: Weigh 10g of calcium-based bentonite with a diameter of 20μm, add 10g of water, raise the temperature to 70°C, stir at a constant temperature for 1.5h, then add 2g of quaternary ammonium salt-73, and continue stirring for 18h to obtain a compound quaternary ammonium salt- 73 bentonite solution, dried bentonite at 60°C, and crushed to 100 mesh to obtain modified bentonite.

[0044]Preparation of modified bentonite loaded with BMP-2: Weigh modified bentonite and dissolve in distilled water to make a bentonite solution with a mass concentration of 25%wt, and add BMP-2 according to the mass ratio of bentonite solution: BMP-2 500000:1 In the modified bentonite, BMP-2 is supported on the modified bentonite gel.

[0045] Prepara...

Embodiment 3

[0047] As an embodiment of the calcium phosphate bone cement described in the present invention, the calcium phosphate bone cement described in this embodiment includes solid phase powder and solidification liquid;

[0048] Preparation of modified bentonite: Weigh 10g of calcium-based bentonite with a diameter of 20μm, add 10g of water, raise the temperature to 70°C, stir at a constant temperature for 1.5h, then add 2g of quaternary ammonium salt-73, and continue stirring for 18h to obtain a compound quaternary ammonium salt- 73 bentonite solution, dried bentonite at 60°C, and crushed to 100 mesh to obtain modified bentonite.

[0049] Preparation of modified bentonite loaded with BMP-2: Weigh modified bentonite and dissolve in distilled water to make a bentonite solution with a mass concentration of 25%wt, and add BMP-2 according to the mass ratio of bentonite solution: BMP-2 350000:1 In the modified bentonite, BMP-2 is supported on the modified bentonite gel.

[0050] Prepar...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Lengthaaaaaaaaaa
Diameteraaaaaaaaaa
Diameteraaaaaaaaaa
Login to View More

Abstract

The invention discloses vertebral body reinforced calcium phosphate bone cement, which has good compressive strength, collapse resistance and osteogenesis induction effect, and can avoid pulmonary embolism caused by collapse in vertebroplasty. The technical scheme of the invention is as follows: the calcium phosphate bone cement comprises solid-phase powder and curing liquid; the solid-phase powder comprises the following components in parts by weight: 90-100 parts of calcium phosphate powder, 5-10 parts of absorbable fibers, 10-20 parts of bone morphogenetic protein-loaded quaternary ammoniumsalt-73 bentonite and 10-30 parts of a developing agent; and the curing liquid comprises the following component in parts by weight: 20-40 parts of a buffer solution. Bentonite is modified by using low-concentration bone morphogenetic protein, and quaternary ammonium salt has positive ions, so that protein binding sites are formed, the bone morphogenetic protein is not easily taken away by body fluid after being combined with the bentonite, and the concentration of the bone morphogenetic protein in the bone cement is not reduced along with time. The toxicity can be reduced, the cost can be reduced, and the bone cement is suitable for wide popularization and application.

Description

technical field [0001] The invention belongs to the field of medical materials and relates to the technical field of bone cement, in particular to a vertebral body reinforced calcium phosphate bone cement and a preparation method thereof. Background technique [0002] Osteoporosis can cause degenerative diseases of the spine, characterized by damage to bone microstructure, decreased bone mass, and increased bone fragility. In the United States, it is estimated that 25% of women over 70 have spinal osteoporosis Vertebral compression fractures (OVCF), the main clinical manifestations are low back pain, limited thoracolumbar movement, and will affect the quality of life of patients. The traditional treatment methods are bed rest, drugs, orthopedic braces, calcium supplementation and other treatments. [0003] In 1987, Galibert et al. in France first reported the use of vertebroplasty (Vertebroplasty, VP) in the treatment of intractable painful C2 vertebral hemangiomas, and ach...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61L27/50A61L27/12A61L27/02A61L27/22A61L27/54
CPCA61L27/50A61L27/12A61L27/02A61L27/227A61L27/54A61L2400/06A61L2430/38A61L2300/252A61L2300/412A61L2400/04C08L89/00
Inventor 车七石单玲星刘少辉张俊辉赵澎
Owner GUANGZHOU RAINHOME PHARM&TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products